Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking

Background: By improving the affordability and accessibility of biologicals, biosimilar competition provides important benefits to healthcare systems and patients. In Belgium, biosimilar uptake and competition is limited compared to other European markets. Whereas other countries have initiated stru...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, Liese, Simoens, Steven, Declerck, Paul, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315422/
https://www.ncbi.nlm.nih.gov/pubmed/35903323
http://dx.doi.org/10.3389/fphar.2022.821616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315422/
https://www.ncbi.nlm.nih.gov/pubmed/35903323
http://dx.doi.org/10.3389/fphar.2022.821616

Ejemplares similares